Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (5): 90-95.doi: 10.6040/j.issn.1671-7554.0.2023.0027

• 公共卫生与管理学 • Previous Articles    

Epidemic and whole genome characteristics of coxsackievirus A16 in Jining in 2021

WANG Shan1,2, JIAO Boyan2, FENG Qiang3, DUAN Yanhua2, WEN Hongling1   

  1. 1. School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    2. Jining Center for Disease Control and Prevention, Jining 272000, Shandong, China;
    3. Renchen Center for Disease Control and Prevention, Jining 272000, Shandong, China
  • Published:2023-05-15

Abstract: Objective To analyze the epidemic and whole genome characteristics of coxsackievirus A16(CV-A16)in Jining in 2021. Methods A total of 513 stool samples were collected from patients with hand, foot and mouth disease(HFMD), which were then underwent nucleic acid detection of CV-A16 and virus isolation. Whole genome sequencing and bioinformatics analysis were performed on 4 CV-A16 strains. Results Altogether 36 cases were positive for CV-A16, with a positive rate of 7.02%(36/513). The positive rate was the highest from July to September. The 4 strains were distributed in B1a and B1b branches. Compared with prototype strain G-10(CAU05876), the 4 strains had homology of nucleotide and amino acid of 77.5%-78.0% and 94.7%-94.9%, respectively. There were multiple amino acid changes in the encoded proteins of the 4 strains. Conclusion CV-A16 was one of the main pathogens of HFMD in Jining in 2021, including B1a and B1b subtypes. The surveillance of the disease should be strengthened.

Key words: Hand, foot and mouth disease, Coxsackievirus A16, Whole genome sequencing

CLC Number: 

  • R373.2
[1] Chen W, Li J, Li J, et al. Roles of non-coding RNAs in virus-host interaction about pathogenesis of hand-foot-mouth disease [J]. Curr Microbiol, 2022, 79(9): 247. doi: 10.1007/s00284-022-02928-z.
[2] Chen Z, Jiang C, Cheng X, et al. Secondary hypogonadism following hand, foot, and mouth disease in an adult: a case report and review of literature [J]. BMC Infect Dis, 2022, 22(1): 56. doi: 10.1186/s12879-022-07030-0.
[3] 黄浩, 盘珍梅, 潘燕兰, 等. 致手足口病肠道病毒的病原学研究进展[J]. 病毒学报, 2021, 37(6): 1491-1501. HUANG Hao, PAN Zhenmei, PAN Yanlan, et al. Research progress on the etiology of enterovirus causing hand foot and mouth disease [J]. Chinese Journal of Virology, 2021, 37(6): 1491-1501.
[4] 张静, 李秀惠, 李丽, 等. 手足口病病原学和流行病学研究进展[J]. 中华流行病学杂志, 2022, 43(5): 771-783. ZHANG Jing, LI Xiuhui, LI Li, et al. Etiology and epidemiology of hand, foot and mouth disease in China [J]. Chinese Journal of Epidemiology, 2022, 43(5): 771-783.
[5] Fang CY, Liu CC. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease [J]. Expert Rev Vaccines, 2018, 17(9): 819-831.
[6] 张斯钰, 董瑞, 赵善露, 等. 2019—2020年湖南省手足口病流行特征和病原学特征研究[J]. 实用预防医学, 2022, 29(1): 22-26. ZHANG Siyu, DONG Rui, ZHAO Shanlu, et al. Epidemic and etiological characteristics of hand-foot-mouth disease in Hunan Province, 2019—2020 [J]. Practical Preventive Medicine, 2022, 29(1): 22-26.
[7] 秦连阳,尹保行,连颜芳,等. 2009—2018年山西省临汾市手足口病流行病学调查分析[J]. 中国卫生监督杂志, 2020, 27(6): 576-580. QIN Lianyang, YIN Baohang, LIAN Yanfang, et al. Epidemiological analysis of hand, foot and mouth disease in Linfen, 2009—2018 [J]. Chinese Journal of Health Inspection, 2020, 27(6): 576-580.
[8] Li P, Chen Y, Tang A, et al. Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis [J]. Arch Public Health, 2021, 79(1): 166. doi: 10.1186/s13690-021-00688-z.
[9] 段延华. 2010—2016年济宁市手足口病流行病学特征分析[J]. 预防医学论坛, 2019, 25(7): 514-517. DUAN Yanhua. Analysis on epidemiological characteristics of hand foot and mouth disease, Jining City, 2010—2016 [J]. Preventive Medicine Tribune, 2019, 25(7): 514-517.
[10] 姜静静, 于兴浩, 颜丙新, 等. 2014—2018年济宁市手足口病流行特征及病原学分析[J]. 医学动物防制, 2021, 37(1): 79-81. JIANG Jingjing, YU Xinghao, YAN Bingxin, et al. Epidemiological characteristics and pathogenic analysis of hand-foot-mouth disease in Jining from 2014 to 2018 [J]. Journal of Medical Pest Control, 2021, 37(1): 79-81.
[11] 刘杨, 郭春艳, 张西嫔, 等. 柯萨奇病毒A16型VP1基因和病毒生物物理学分析[J]. 中华实验和临床感染病杂志(电子版), 2015, 9(2): 28-32. LIU Yang, GUO Chunyan, ZHANG Xipin, et al. Characterization of the VP1 region and biophysics of Coxsackievirus A16 [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Version), 2015, 9(2): 28-32.
[12] Mao Q, Wang Y, Yao X, et al. Coxsackievirus A16: epidemiology, diagnosis, and vaccine [J]. Hum Vaccin Immunother, 2014, 10(2): 360-367.
[13] Ding Y, Wang Z, Zhang X, et al. Different antibody response against the coxsackievirus A16 VP1 capsid protein: specific or non-specific [J]. PLoS One, 2016, 11(9): e0162820. doi: 10.1371/journal.pone.0162820.
[14] Shi J, Huang X, Liu Q, et al. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16 [J]. Vaccine, 2013, 31(17): 2130-2136.
[15] Guo J, Cao Z, Liu H, et al. Epidemiology of hand, foot, and mouth disease and the genetic characteristics of Coxsackievirus A16 in Taiyuan, Shanxi, China from 2010 to 2021 [J]. Front Cell Infect Microbiol, 2022, 12: 1040414. doi: 10.3389/fcimb.2022.1040414.
[16] Cheng D, Chiu YW, Huang SW, et al. Genetic and cross neutralization analyses of coxsackievirus A16 circulating in Taiwan from 1998 to 2021 suggest dominant genotype B1 can serve as vaccine candidate [J]. Viruses, 2022, 14(10): 2306. doi: 10.3390/v14102306.
[17] Mao Q, Wang Y, Yao X, et al. Coxsackievirus A16: epidemiology, diagnosis, and vaccine [J]. Hum Vaccin Immunother, 2014, 10(2): 360-367.
[18] 张丽芬, 周雪花, 徐敏, 等. 2019年云南省文山州柯萨奇病毒A16型的基因特征[J]. 昆明医科大学学报, 2020, 41(11): 18-24. ZHANG Lifen, ZHOU Xuehua, XU Min, et al. Genetic characteristic analysis of coxsackievirus A16 in Wenshan Prefecture of Yunnan Province in 2019 [J]. Journal of Kunming Medical University, 2020, 41(11): 18-24.
[19] Yi L, Zeng H, Zheng H, et al. Molecular surveillance of coxsackievirus A16 in southern China, 2008—2019 [J]. Arch Virol, 2021, 166(6): 1653-1659.
[20] Han Z, Song Y, Xiao J, et al. Genomic epidemiology of coxsackievirus A16 in mainland of China, 2000-18 [J]. Virus Evol, 2020, 6(2): veaa084. doi: 10.1093/ve/veaa084.
[21] 文婕, 王鹏飞, 李秀芳, 等. 2015年昆明市柯萨奇病毒A16型VP1区基因特征分析[J]. 中华疾病控制杂志, 2018, 22(6): 607-612. WEN Jie, WANG Pengfei, LI Xiufang, et al. Genetic characteristics analyses of the VP1 gene in coxsackievirus A16 isolates from Kunming in 2015 [J]. Chinese Journal of Disease Control & Prevention, 2018, 22(6): 607-612.
[22] 赵怀龙, 隋竑弢, 杨国樑, 等. 2017年济南市柯萨奇病毒A16型VP1基因特征分析[J]. 中华实验和临床病毒学杂志, 2019, 33(1): 44-48. ZHAO Huailong, SUI Hongtao, YANG Guoliang, et al. Characteristics of coxsackievirus A16 VP1 gene in Jinan, 2017 [J]. Chinese Journal of Experimental and Clinical Virology, 2019, 33(1): 44-48.
[23] Kumar R, Mehta D, Mishra N, et al. Role of host-mediated post-translational modifications(PTMs)in RNA virus pathogenesis [J]. Int J Mol Sci, 2020, 22(1): 323. doi: 10.3390/ijms22010323.
[24] Chamontin C, Bossis G, Nisole S, et al. Regulation of viral restriction by post-translational modifications [J]. Viruses, 2021, 13(11): 2197. doi: 10.3390/v13112197.
[25] Loboda AP, Soond SM, Piacentini M, et al. Lysine-specific post-translational modifications of proteins in the life cycle of viruses [J]. Cell Cycle, 2019, 18(17): 1995-2005.
[26] 徐莉. 中国手足口病中柯萨奇病毒A16流行株全基因组特征分析[D]. 杭州: 浙江大学, 2019.
[1] BAI Yongjuan, ZHUANG Zhichao, HAO Shubin, WANG Lihong, LI Chun, LU Yan, ZHAO Li, WANG Zhiyu, WEN Hongling. Rescue of 3D recombinant enterovirus 71 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 7-12.
[2] LI Jing, QIAO Qiao, SUN Lele, MA Yingwei, ZHUANG Zhichao, ZHAO Li, WANG Zhiyu, WEN Hongling. Cell injury induced by 3CD protein of Enterovirus 71 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 16-19.
[3] MA Yingwei, SUN Lele, LI Jing, QIAO Qiao, ZHUANG Zhichao, ZHAO Li, YU Xuejie, WANG Zhiyu, WEN Hongling, SUN Yanlin. Construction of the minireplicon of enterovirus 71 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(9): 35-40.
[4] YUAN Xiao-jing1, WEN Hong-ling1, GAO Feng2, XU Hong-Zhi1, SI Lu-ying1, WANG Dong-xu1, SONG Yan-yan1, ZHAO Li1, WANG Zhi-yu1. Sequence analysis for 5′untranslated region of
genomes from enterovirus 71
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 127-.
[5] ONG Nan-nan1, ZHANG Ying2, LI Peng1, YUE Ying-ying1, LI Zhi-hui1, GAI Zhong-tao2, MENG Hong1. Analysis of the pathogenic characteristics of BALB/c
mice infected with enterovirus 71 isolates
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 35-.
[6] WANG Dong-xu1, WEN Hong-ling1, DONG Hua1, SUN Cheng-xi1, SI Lu-ying1,YUAN Xiao-jing1, CHU Fu-lu1, ZHAO Li1, WANG Zhi-yu1,2. Immunological effect of different immunization schedules on enterovirus 71 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 129-.
[7] YUE Ying-ying1, ZHANG Ying2, LI Peng1, LI Zhi-hui1, SONG Nan-nan1, JI Xuan1, GAI Zhong-tao2, MENG Hong1. Isolation and identification of enterovirus 71 in endotracheal
aspirates from a patient with hand-foot-mouth disease
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 106-109.
[8] LI Zhi-hui, YUE Ying-ying, SONG Nan-nan, LI Peng, MENG Hong. Toward constructing a mucosa vaccine for enterovirus 71 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 25-.
[9] LI Peng1, ZHANG Ying2, YUE Ying-ying1, SONG Nan-nan1, LI Zhi-hui1, GAI Zhong-tao2, MENG Hong1. Complete genome sequence analysis of enterovirus 71 JN200804 strain isolated in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(10): 113-117.
[10] LI Zhi-hui, LI Peng, SONG Nan-nan, YUE Ying-ying, JI Xuan, ZHAO Yuan-hao, MENG Hong. Application of sensitized sheep erythrocytes in cell tropism of EV71 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(11): 33-.
[11] TIAN Ming-zhong1 ,GAO Jie1, WANG Dong-qiu1, ZHU Chang-jun2. Gene therapy of endoribonucleaseⅢ-prepared siRNAs (esiRNA) library for HBV infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(7): 42-46.
[12] BU Fan-feng,LU Yan-qin,HAN Jin-xiang,WANG Li-na,FENG Zhao-lei,SHEN Zhong-lin,GAO Gang. Determination of hepatitis B virus genotypes and lamivudine resistant mutations by RFLP [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(11): 1139-1143.
[13] LU Yan-qin,HAN Jin-xiang,SHEN Zhong-lin,ZHU Bo. Hybridization detection of mutation sites in hepatitis B virus using oligodeoxynucleotide and PNA array [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(7): 673-676.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!